Heart Disease Clinical Trials in Miami

Showing 41-60 of 132 trials

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

NCT04766892

This is a Phase 2a proof-of-concept study to assess safety, tolerability, and preliminary efficacy of mavacamten treatment on biomarker levels in participants with heart failure with preserved ejection fraction (HFpEF) and elevation of NT-proBNP with or without elevation of cTnT. Data from this study will inform future study designs of mavacamten in patients with HFpEF.

Heart Failure With Preserved Ejection Fraction

Bristol-Myers Squibb30 participantsStarted Mar 2021

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +18 more locations

COMPLETEDNA< 1 mile

Benefits of Microcor in Ambulatory Decompensated Heart Failure

NCT04096040

To assess investigator engagement of μCor system data in the context of heart failure management. The μCor system includes a sensor and wearable patch for fluid management.

Heart Failure

Zoll Medical Corporation265 participantsStarted Nov 2019

Sheffield, Alabama, United States • El Cajon, California, United States • Inglewood, California, United States +80 more locations

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

Benefits of Microcor in Ambulatory Decompensated Heart Failure

Heart Disease Trials in Other Cities

Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI)

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Benefits of µCor in Ambulatory Decompensated Heart Failure

Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)

Evaluating Mobile Health Tool Use for Capturing Patient-centered Outcomes Measures in HF Patients

Off-pump Versus On-pump Coronary Artery Bypass Grafting in Frail Patients

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Guideline Directed Medical Therapy (GDMT) Optimization and Adherence Longitudinal Study for Heart Failure.

Cardionomic STOP-ADHF Study

Effect of Adaptive Servo Ventilation (ASV) on Survival and Hospital Admissions in Heart Failure

Other Conditions in Miami